Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 7,400 shares at $129.44 ($968K) on 2018-04-25, disclosed to the SEC on 2018-04-26.
Open-market sale of $968k LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $128.30 | 800 | $103K | 10.6% |
| 2 | $129.44 | 800 | $104K | 10.7% |
| 3 | $130.71 | 2,400 | $314K | 32.4% |
| 4 | $131.84 | 3,400 | $448K | 46.3% |
| Total | $130.83 avg | 7,400 | $968K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $2.7M | — | Filing → |
| LOXO | SELL | 2018-12-12 | $1.0M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.2M | — | Filing → |